HDL-C


Also found in: Acronyms.

HDL-C

 
high-density-lipoprotein cholesterol; see cholesterol.

HDL-C

high-density-lipoprotein cholesterol.

HDL-C

abbreviation for high-density-lipoprotein cholesterol. See cholesterol.

HDL-C

Abbreviation for high density lipoprotein cholesterol.
References in periodicals archive ?
67 mg/dL) in HDL-C was associated with a 9-mL lower [FEV.
The mean value of HDL-C was low in participants with MetS as compared to participants without MetS; showing statistically significant difference as detailed in Graph 3.
The Seralyzer HDL-C test provides a reliable and accurate measure of the HDL-C concentrtaion.
The AHA determined that women require a higher HDL-C level than men, or an HDL-C no lower than 50 mg/dL, while men require an HDL-C level no lower than 40 mg/dL according to NCEP ATP III guidelines.
Although both approaches have helped establish HDL-P as a potentially relevant clinical metric, only limited evidence suggests that it is substantially independent of HDL-C (17, 18).
The launch of Niaspan in Canada represents a major milestone for Oryx and we are pleased to be able to make available this significant new therapy to all Canadians who may benefit from increasing their HDL-C," stated Douglas Reynolds, President of Oryx.
One of the main goals of this study was to examine other biomarkers of HDL besides HDL-C that could be measured with automated and readily implemented methods in a routine clinical laboratory for cardiovascular risk assessment.
The Liquid N-geneous HDL-C assay (Genzyme Diagnostics) uses a polyanion that selectively complexes LDL, VLDL, and chylomicrons followed by a detergent that selectively solubilizes HDL.
Because of the inverse correlation that exists between serum HDL-C concentration and risk of atherosclerotic disease (1), monitoring of high-density lipoprotein cholesterol (HDL-C) in serum is clinically important.
This particular patent further substantiates the safety and tolerability of our Niaspan franchise and illustrates our continued investment in research and development on Niaspan therapy, the most effective treatment for raising low HDL-C ("good" cholesterol).
1], in this issue, demonstrates the inadequacy of a phosphotungstate precipitation method for HDL-C and proposes the use of HPLC as a tool to compare analytical methods for HDL-C.